Lantheus Holdings, Inc. [LNTH] - Lantheus Holdings / Curium US Holdings merger
Lantheus Holdings, Inc. will merge with Curium US Holdings LLC, with each outstanding share of Lantheus common stock to be converted into a right to receive cash, subject to the terms of the merger agreement.
Why this matters
Lantheus Holdings, Inc., a company specializing in in vitro and in vivo diagnostic substances, is set to merge with Curium US Holdings LLC. This merger follows Lantheus's exploration of strategic alternatives, including potential acquisition and sale transactions, as part of its ongoing efforts to enhance shareholder value. Under the terms of the merger agreement, each outstanding share of Lantheus common stock will be converted into the right to receive cash. The merger is expected to be completed in the first half of 2027, contingent upon stockholder approval, regulatory clearances, and other customary closing conditions.